Cargando…
miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
BACKGROUND: miR-29c has been associated with the progression of many cancers. However, the function and mechanism of miR-29c have not been well investigated in breast cancers. METHODS: Real-time quantitative PCR was used to assess expression of miR-29c and DNMT3B mRNA. Western blot and immunochemist...
Autores principales: | Li, Wan, Yi, Jie, Zheng, Xiangjin, Liu, Shiwei, Fu, Weiqi, Ren, Liwen, Li, Li, Hoon, Dave S. B., Wang, Jinhua, Du, Guanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956756/ https://www.ncbi.nlm.nih.gov/pubmed/29796115 http://dx.doi.org/10.1186/s13148-018-0495-y |
Ejemplares similares
-
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
por: Li, Wan, et al.
Publicado: (2022) -
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
por: Fiorentino, Loredana, et al.
Publicado: (2013) -
3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
por: Li, Wan, et al.
Publicado: (2018) -
Correction: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
por: Li, Wan, et al.
Publicado: (2022) -
A narrative review of research progress on drug therapies for glioblastoma multiforme
por: Zheng, Xiangjin, et al.
Publicado: (2021)